Lupi-Fsh 150 Injection

generic_icon
Rs.2028for 1 vial(s) (2 ml Injection each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition FOR Lupi-Fsh 150IU Injection

Urofollitropin(150IU)

food interaction for Lupi-Fsh Injection

alcohol interaction for Lupi-Fsh Injection

pregnancy interaction for Lupi-Fsh Injection

lactation interaction for Lupi-Fsh Injection

food
alcohol
pregnancy
lactation
No interaction found/established
It is unsafe to consume alcohol with Lupi-Fsh 150 Injection.
UNSAFE
Lupi-Fsh 150 Injection is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
UNSAFE
Information regarding the use of Lupi-Fsh 150 Injection during breastfeeding is not available. Please consult your doctor.
CONSULT YOUR DOCTOR

SALT INFORMATION FOR Lupi-Fsh 150IU Injection

Urofollitropin(150IU)

Lupi-fsh injection uses

{med_name} is used in the treatment of female infertility. It is used in women who have a problem with ovulation or are undergoing fertility treatment like in-vitro fertilization.

How lupi-fsh injection works

In females, Lupi-Fsh 150 Injection works by stimulating the release of estrogen which helps in the growth and development of the egg before release. It also helps to develop more follicles (eggs) in women undergoing assisted reproductive technology procedures.

Common side effects of lupi-fsh injection

Abdominal pain, Headache, Bloating, Pelvic pain, Abdominal cramp, Nausea, Respiratory disorder, Hot flushes

SUBSTITUTES FOR Lupi-Fsh Injection

28 Substitutes
28 Substitutes
Sorted By
RelevancePrice

Expert advice FOR Lupi-Fsh Injection

  • Your doctor may prescribe more than one medicine as part of a pregnancy plan.
  • The injection is administered under the skin. Follow the recommended dosage and monitoring schedules to minimise the possibility of ovarian hyperstimulation.
  • Inform your doctor immediately if you have severe pelvic pain, nausea, vomiting, diarrhea, sudden weight gain, trouble breathing, or decreased or no urination during treatment, as these could be symptoms of ovarian hyperstimulation syndrome (OHSS).
  • Do not use Urofollitropin if you are already pregnant or breastfeeding.
  • Pregnancy following treatment with Urofollitropin is more likely to result in a multiple pregnancy (twins or more) than if you had conceived naturally.
  • Urofollitropin stimulates the production of eggs in women having treatment for anovulatory infertility.

Frequently asked questions FOR Lupi-Fsh 150IU Injection

Urofollitropin

Q. How and in what dose should I take Lupi-Fsh 150 Injection?
It is given as an injection just under the skin by a medical healthcare professional only. The dose and treatment duration depends on your ovarian response for which you would be constantly monitored by your doctor during the treatment.
Q. What if I miss a dose of Lupi-Fsh 150 Injection?
Ideally, you should try not to miss a dose of Lupi-Fsh 150 Injection. However, please talk to your doctor as soon as you remember that you have missed a dose.
Q. What are the side effects of using Lupi-Fsh 150 Injection?
The most common side effects are headache and pain in the abdomen. The other common side effects include hot flushes, nausea, vomiting, diarrhea, rashes and breast tenderness. If any of these side effects bother you, please consult with your doctor. In addition, this medicine may increase the likelihood of conditions like ovarian hyperstimulation syndrome (OHSS) and multiple pregnancy.
Show More
Q. What is Lupi-Fsh 150 Injection, and what is it used for?
Lupi-Fsh 150 Injection contains a medicine called Urofollitropin. Urofollitropin is a type of follicle stimulating hormone (FSH). It helps to treat women who can not become pregnant because their ovaries do not produce eggs [including polycystic ovary disease (PCOD)]. It is also used in assisted reproductive technology (ART) procedures such as in-vitro fertilization (IVF), which help women to become pregnant.

Content on this page was last updated on 14 April, 2025, by Dr. Rajeev Sharma (MBA, MBBS)